Cover Image
市場調查報告書

Bsim2- 產品平台檢討

Bsim2 - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 331742
出版日期 內容資訊 英文 16 Pages
訂單完成後即時交付
價格
Back to Top
Bsim2- 產品平台檢討 Bsim2 - Product Pipeline Review - 2015
出版日期: 2015年04月29日 內容資訊: 英文 16 Pages
簡介

Bsim2是總公司設在葡萄牙的生物科技企業。利用電腦及其工作流程,著重發現以Amyloid原因的神經退化性疾病的候選藥物物質。遺傳性多發性神經病變,遺傳性澱粉樣心肌病,也有老年癡呆症等分子治療藥的開發平台。

本報告提供Bsim2的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

Bsim2基本資料

  • Bsim2概要
  • 主要資訊
  • 企業資料

Bsim2:R&D概要

  • 主要的治療範圍

Bsim2:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Bsim2:開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發階段的產品/聯合治療模式

Bsim2:藥物簡介

  • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Alzheimer's Disease
  • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Cardiomyopathy
  • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Polyneuropathy

Bsim2:開發平台分析

Bsim2:各分子類型的開發中產品

Bsim2:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC07036CDB

Summary

Global Markets Direct's, 'Bsim2 - Product Pipeline Review - 2015', provides an overview of the Bsim2's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bsim2's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Bsim2 including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Bsim2's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Bsim2's pipeline products

Reasons to buy

  • Evaluate Bsim2's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Bsim2 in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Bsim2's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Bsim2 and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bsim2
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Bsim2 and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bsim2 Snapshot
    • Bsim2 Overview
    • Key Information
    • Key Facts
  • Bsim2 - Research and Development Overview
    • Key Therapeutic Areas
  • Bsim2 - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Bsim2 - Pipeline Products Glance
    • Bsim2 - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Bsim2 - Drug Profiles
    • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Cardiomyopathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Polyneuropathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bsim2 - Pipeline Analysis
  • Bsim2 - Pipeline Products by Molecule Type
  • Bsim2 - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bsim2, Key Information
  • Bsim2, Key Facts
  • Bsim2 - Pipeline by Indication, 2015
  • Bsim2 - Pipeline by Stage of Development, 2015
  • Bsim2 - Monotherapy Products in Pipeline, 2015
  • Bsim2 - Discovery, 2015
  • Bsim2 - Pipeline by Molecule Type, 2015

List of Figures

  • Bsim2 - Pipeline by Top 10 Indication, 2015
Back to Top